Hydrofracking Lawsuit Results in $2.9M Jury Award for Private Nuisance

|

A Texas jury has awarded $2.9 million in damages against a hydraulic fracturing company, in a lawsuit filed by a family that alleged gas extraction wells caused pollution, decreased value of their land and a variety of health problems.

Hydraulic fracturing, which is more commonly known as hydrofracking or just fracking, is the controversial process for getting at pockets of natural gas trapped underground.

In recent years, oil and gas companies have been using the process to blast a secret mix of chemicals, sand, water and other substances into the ground at high pressure, fracturing the bedrock and releasing the gas for extraction. The companies have refused to release the ingredients in the chemical cocktails injected into the ground using laws to protect them from revealing company secrets.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The verdict was handed down on Tuesday by a Dallas County court jury, in an environmental tort lawsuit was filed by Bob and Lisa Parr, as well as their daughter, Emma Duval, against Aruba Petroleum Inc.

According allegations raised in the hydrofracking lawsuit, nearly two dozen wells near their property caused a private nuisance, exposing them to toxic chemicals that damaged their health and lowered property value.

Environmentalists, a number of lawmakers, local communities and consumer advocacy groups have expressed concerns for years that hydrofracking presents a threat to groundwater supplies and the environment.

The Parr lawsuit was originally filed in 2011, also including Halliburton, Encana Oil & Gas and Burlington Resources Oil & Gas Co. as defendants. However, the Parrs settled for about $400,000 with Encana and Burlington. Halliburton convinced a judge to dismiss the claims against it in 2013, leaving only Aruba as a defendant.

The family has been prevented from pursuing injury claims against the company, and the negligence lawsuit focuses primarily on the loss of property value due to the company’s activities and the alleged pollution and waste caused by the gas wells.

The jury awarded the $2.925 million verdict on the grounds that the company had been a private nuisance for the Parr family. The jury found that Aruba intentionally took steps to interfere with the Parr family’s use of its 40-acre property, but did not find that the company acted with malice and refused to grant punitive damages. The monetary award represented compensatory damages for pain, suffering, and loss of land value.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A federal judge has set a February 2027 trial date for an Amazon fire pit lawsuit alleging that a teenager suffered severe burn injuries after a relative attempted to relight the device.
An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers.
All Ozempic and Wegovy vision loss lawsuits have been consolidated before the same federal judge overseeing related claims alleging stomach paralysis linked to the medications.